Article
Novel Theophylline Oral Formulation for Pediatric Use and Biological Evaluation
2025-09-04
Abstract excerpt
<h4>Background: </h4> In all drug development phases, measures of safety and efficacy parameters are crucial. Asthma, a global public health issue, seriously affects the life quality of children. Theophylline, a phosphodiesterase inhibitor, is a drug that has been employed in treating respiratory diseases. In fact, pediatric formulation of theophylline for this purpose do not exist. Objective. Development and eval...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fca8fdc9-351b-521a-bb97-cb94c16ec723
- DOI
- 10.20944/preprints202509.0456.v1
